Cited by 1,424Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 223 of the 225 references it cites were found in a registry or an index.

Alzheimer’s Disease: The Challenge of the Second Century

Open access

Holtzman, David M., Morris, John C., Goate, Alison M.·2011·Science Translational Medicine

DOI 10.1126/scitranslmed.3002369PMC PMC3130546

Open this paper in CoChat — free account

Abstract

In the first of our State of the Art Review series, David M. Holtzman, John C. Morris, and Alison M. Goate explore the rapid pace of Alzheimer’s disease research and the challenges to translating research breakthroughs into clinical treatments.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.3002369

Cites

223 of 223 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

2 retracted

RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769
Retracted
RETRACTED ARTICLE: APP binds DR6 to trigger axon pruning and neuron death via distinct caspases
Nikolaev, A., McLaughlin, T., O’Leary, D. D. M., & Tessier-Lavigne, M. (2009) · Nature · doi:10.1038/nature07767 · Cited by 992
Retracted
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
A default mode of brain function
Raichle, M. E., MacLeod, A. M., Snyder, A. Z., Powers, W. J., Gusnard, D. A., & Shulman, G. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.676 · Cited by 12,190
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Self-citation
Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Finding the missing heritability of complex diseases
Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., McCarthy, M. I., Ramos, E. M., Cardon, L. R., Chakravarti, A., et al. (2009) · Nature · doi:10.1038/nature08494 · Cited by 8,336
Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806

Show all 225 references

Sorted by citations

Items 401–500 of 1,001

Exercise and estrogen: common pathways in Alzheimer’s disease pathology
Bagit, A., Hayward, G. C., & MacPherson, R. E. K. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00008.2021 · Cited by 57
Heme oxygenase‐1: The roles of both good and evil in neurodegenerative diseases
Liu, R., Yang, J., Li, Y., Xie, J., & Wang, J. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15969 · Cited by 57
A genome-wide association study combining pathway analysis for typical sporadic amyotrophic lateral sclerosis in Chinese Han populations
Xie, T., Deng, L., Mei, P., Zhou, Y., Wang, B., Zhang, J., Lin, J., Wei, Y., Zhang, X., & Xu, R. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.014 · Cited by 57
Bridging Integrator 1 (BIN1) Genotype Effects on Working Memory, Hippocampal Volume, and Functional Connectivity in Young Healthy Individuals
Zhang, X., Yu, J., Li, J., Wang, C., Tan, L., Liu, B., & Jiang, T. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.30 · Cited by 57
Phospho-dependent ubiquitination and degradation of PAR-1 regulates synaptic morphology and tau-mediated Aβ toxicity in Drosophila
Lee, S., Wang, J.-W., Yu, W., & Lu, B. (2012) · Nature Communications · doi:10.1038/ncomms2278 · Cited by 57
Diurnal Patterns of Soluble Amyloid Precursor Protein Metabolites in the Human Central Nervous System
Zakaria, J. A. D., Kasten, T. P., Huang, Y., Benzinger, T. L. S., Sigurdson, W. C., Ovod, V., Morris, J. C., & Bateman, R. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089998 · Cited by 57
Self-citation
Alzheimer's disease in a dish: promises and challenges of human stem cell models
Young, J. E., & Goldstein, L. S. B. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds319 · Cited by 57
The Critical Role of Nurr1 as a Mediator and Therapeutic Target in Alzheimer’s Disease-related Pathogenesis
Jeon, S. G., Yoo, A., Chun, D. W., Hong, S. B., Chung, H., Kim, J.-I., & Moon, M. (2020) · Aging and Disease · doi:10.14336/ad.2019.0718 · Cited by 57
Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer’s Disease: Results from the DIAN Study Group
Su, Y., Blazey, T. M., Owen, C. J., Christensen, J. J., Friedrichsen, K., Joseph-Mathurin, N., Wang, Q., Hornbeck, R. C., Ances, B. M., Snyder, A. Z., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0152082 · Cited by 56
Self-citation
Genetic variants associated with Alzheimer’s disease confer different cerebral cortex cell-type population structure
The Dominantly Inherited Alzheimer Network (DIAN), Li, Z., Del-Aguila, J. L., Dube, U., Budde, J., Martinez, R., Black, K., Xiao, Q., Cairns, N. J., Dougherty, J. D., et al. (2018) · Genome Medicine · doi:10.1186/s13073-018-0551-4 · Cited by 56
Self-citation
The microbiome: A target for Alzheimer disease?
Seo, D.-O., Boros, B. D., & Holtzman, D. M. (2019) · Cell Research · doi:10.1038/s41422-019-0227-7 · Cited by 56
Self-citation
A Comprehensive Insight into the Mechanisms of Dopamine in Disrupting Aβ Protofibrils and Inhibiting Aβ Aggregation
Chen, Y., Li, X., Zhan, C., Lao, Z., Li, F., Dong, X., & Wei, G. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00306 · Cited by 56
MEK1/2 inhibition rescues neurodegeneration by TFEB-mediated activation of autophagic lysosomal function in a model of Alzheimer’s Disease
Chun, Y. S., Kim, M., Lee, S., Kim, M. J., Hong, T.-J., Jeon, J. K., Ganbat, D., Kim, H. T., Kim, S. S., Kam, T., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01713-5 · Cited by 56
Systems biology of neurodegenerative diseases
Wood, L. B., Winslow, A. R., & Strasser, S. D. (2015) · Integrative Biology · doi:10.1039/c5ib00031a · Cited by 56
MiR-126 Regulates Growth Factor Activities and Vulnerability to Toxic Insult in Neurons
Kim, W., Noh, H., Lee, Y., Jeon, J., Shanmugavadivu, A., McPhie, D. L., Kim, K., Cohen, B. M., Seo, H., & Sonntag, K. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8989-x · Cited by 56
Neurodegeneration as an RNA disorder
Johnson, R., Noble, W. J., Tartaglia, G. G., & Buckley, N. J. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.09.006 · Cited by 56
Hippocampal administration of chondroitinase ABC increases plaque-adjacent synaptic marker and diminishes amyloid burden in aged APPswe/PS1dE9 mice
Howell, M. D., Bailey, L. A., Cozart, M. A., Gannon, B. M., & Gottschall, P. E. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0233-z · Cited by 56
Microvascular ultrastructural changes precede cognitive impairment in the murine APPswe/PS1dE9 model of Alzheimer’s disease
Kelly, P., Denver, P., Satchell, S. C., Ackermann, M., Konerding, M. A., & Mitchell, C. A. (2017) · Angiogenesis · doi:10.1007/s10456-017-9568-3 · Cited by 56
Microglial Immunometabolism in Alzheimer’s Disease
Shippy, D. C., & Ulland, T. K. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.563446 · Cited by 56
Roles of eukaryotic elongation factor 2 kinase (eEF2K) in neuronal plasticity, cognition, and Alzheimer disease
Ma, T. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15541 · Cited by 55
Touchscreen games to detect cognitive impairment in senior adults. A user-interaction pilot study
Valladares-Rodriguez, S., Fernández-Iglesias, M. J., Anido-Rifón, L., Facal, D., Rivas-Costa, C., & Pérez-Rodríguez, R. (2019) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2019.04.012 · Cited by 55
An Overview of the Involvement of D-Serine in Cognitive Impairment in Normal Aging and Dementia
Orzylowski, M., Fujiwara, E., Mousseau, D. D., & Baker, G. B. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.754032 · Cited by 55
The Anti-Tumor Histone Deacetylase Inhibitor SAHA and the Natural Flavonoid Curcumin Exhibit Synergistic Neuroprotection against Amyloid-Beta Toxicity
Meng, J., Li, Y., Camarillo, C., Yao, Y., Zhang, Y., Xu, C., & Jiang, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085570 · Cited by 55
Increased CSF Aβ during the very early phase of cerebral Aβ deposition in mouse models
Maia, L. F., Kaeser, S. A., Reichwald, J., Lambert, M., Obermüller, U., Schelle, J., Odenthal, J., Martus, P., Staufenbiel, M., & Jucker, M. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201505026 · Cited by 55
Conversion of Synthetic Aβ toIn VivoActive Seeds and Amyloid Plaque Formation in a Hippocampal Slice Culture Model
Novotny, R., Langer, F., Mahler, J., Skodras, A., Vlachos, A., Wegenast‐Braun, B. M., Kaeser, S. A., Neher, J. J., Eisele, Y. S., Pietrowski, M. J., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0258-16.2016 · Cited by 55
Beta-secretase inhibitors in phase I and phase II clinical trials for Alzheimer’s disease
Moussa, C. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1369527 · Cited by 55
Selective memory and behavioral alterations after ambient ultrafine particulate matter exposure in aged 3xTgAD Alzheimer’s disease mice
Jew, K., Herr, D., Wong, C., Kennell, A., Morris‐Schaffer, K., Oberdörster, G., O’Banion, M. K., Cory‐Slechta, D. A., & Elder, A. C. P. (2019) · Particle and Fibre Toxicology · doi:10.1186/s12989-019-0323-3 · Cited by 55
Retinal nerve fiber layer thickness predicts CSF amyloid/tau before cognitive decline
Asanad, S., Fantini, M., Sultan, W., Nassisi, M., Felix, C. M., Wu, J., Karanjia, R., Ross‐Cisneros, F. N., Sagare, A. P., Zloković, B. V., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0232785 · Cited by 55
Naringin ameliorates memory deficits and exerts neuroprotective effects in a mouse model of Alzheimer's disease by regulating multiple metabolic pathways
Meng, X., Fu, M., Wang, S., Chen, W., Wang, J., & Zhang, N. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.11971 · Cited by 55
Antibody Therapeutics Targeting Aβ and TauPreprint
Gallardo, G., & Holtzman, D. M. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024331 · Cited by 55
Self-citation
Toward a multifactorial model of Alzheimer disease
Storandt, M., Head, D. M., Fagan, A. M., Holtzman, D. M., & Morris, J. C. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.11.029 · Cited by 54
Self-citation
Chronic Sleep Restriction Induces Cognitive Deficits and Cortical Beta‐Amyloid Deposition in Mice via BACE 1‐Antisense Activation
Zhao, H., Wu, H., He, J., Zhuang, J., Liu, Z., Huang, L., & Zhao, Z. (2017) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12667 · Cited by 54
PET Imaging for Early Detection of Alzheimer’s Disease
Bao, W., Jia, H., Finnema, S. J., Cai, Z., Carson, R. E., & Huang, Y. H. (2017) · PET Clinics · doi:10.1016/j.cpet.2017.03.001 · Cited by 54
AMPA-ergic regulation of amyloid-β levels in an Alzheimer’s disease mouse model
Hettinger, J. C., Lee, H. J., Bu, G., Holtzman, D. M., & Cirrito, J. R. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0256-6 · Cited by 54
Self-citation
Dietary Restriction and Neuroinflammation: A Potential Mechanistic Link
Bok, E., Jo, M., Lee, S., Lee, B.-R., Kim, J., & Kim, H.-J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030464 · Cited by 53
“of amyloid plaques and neurofibrillary tangles (NTFs), mainly composed of extracellular amyloid beta (Aβ) and intracellular tau, respectively [119].”
Background
Effects of CD2-associated protein deficiency on amyloid-β in neuroblastoma cells and in an APP transgenic mouse model
Liao, F., Jiang, H., Srivatsan, S., Xiao, Q., Lefton, K. B., Yamada, K., Mahan, T. E., Lee, J.-M., Shaw, A. S., & Holtzman, D. M. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0006-y · Cited by 53
Self-citation
Facilitated brain delivery of poly (ethylene glycol)–poly (lactic acid) nanoparticles by microbubble-enhanced unfocused ultrasound
Yao, L., Song, Q., Bai, W., Zhang, J., Miao, D., Jiang, M., Wang, Y., Shen, Z., Hu, Q., Gu, X. Q., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.043 · Cited by 53
A death receptor 6-amyloid precursor protein pathway regulates synapse density in the mature CNS but does not contribute to Alzheimer’s disease-related pathophysiology in murine models.
Kallop, D. Y., Meilandt, W. J., Gogineni, A., Easley-Neal, C., Wu, T., Jubb, A. M., Yaylaoglu, M., Shamloo, M., Tessier-Lavigne, M., Scearce-Levie, K., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.4963-13.2014 · Cited by 54
Modulating disease-relevant tau oligomeric strains by small molecules
Cascio, F. L., García, S., Montalbano, M., Puangmalai, N., McAllen, S., Pace, A., Piccionello, A. P., & Kayed, R. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.014630 · Cited by 53
Use of Standardized Uptake Value Ratios Decreases Interreader Variability of [18F] Florbetapir PET Brain Scan Interpretation
Nayate, A. P., Dubroff, J. G., Schmitt, J. E., Nasrallah, I. M., Kishore, R., Mankoff, D. A., Pryma, D. A., & Initiative, A. D. N. (2015) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4281 · Cited by 52
SEQUIN Multiscale Imaging of Mammalian Central Synapses Reveals Loss of Synaptic Connectivity Resulting from Diffuse Traumatic Brain Injury
Sauerbeck, A. D., Gangolli, M., Reitz, S. J., Salyards, M. H., Kim, S., Hemingway, C., Gratuze, M., Makkapati, T., Kerschensteiner, M., Holtzman, D. M., et al. (2020) · Neuron · doi:10.1016/j.neuron.2020.04.012 · Cited by 53
Self-citation
Association of APOE With Primary Open-Angle Glaucoma Suggests a Protective Effect for APOE ε4
Margeta, M. A., Letcher, S. M., Igo, R. P., Cooke Bailey, J. N., Pasquale, L. R., Haines, J. L., Butovsky, O., Wiggs, J. L., & for the NEIGHBORHOOD consortium (2020) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.61.8.3 · Cited by 51
Nanotube breakthroughs: unveiling the potential of carbon nanotubes as a dual therapeutic arsenal for Alzheimer’s disease and brain tumors
Elsori, D. H., Rashid, G., Khan, N. A., Sachdeva, P., Jindal, R., Kayenat, F., Sachdeva, B., Kamal, M. A., Babker, A. M. A., & Fahmy, S. A. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1265347 · Cited by 51
Mass Spectrometric Characterization of Amyloid-β Species in the 7PA2 Cell Model of Alzheimer's Disease
Portelius, E., Olsson, M., Brinkmalm, G., Rüetschi, U., Mattsson, N., Andréasson, U., Gobom, J., Brinkmalm, A., Hölttä, M., Blennow, K., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120994 · Cited by 51
Elevation of Brain Magnesium Prevents and Reverses Cognitive Deficits and Synaptic Loss in Alzheimer's Disease Mouse Model
Li, W., Jia, Y., Liu, Y., Huang, X., Abumaria, N., Zhu, Y., Huang, X., Xiong, W., Ren, C., Liu, X., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4610-12.2013 · Cited by 51
Retracted
Lipid raft disarrangement as a result of neuropathological progresses: A novel strategy for early diagnosis?
Marín, R., Rojo, J. A. P., Fabelo, N., Fernandez, C. E., & Díaz, M. L. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.025 · Cited by 51
Exploring Alzheimer Molecular Pathology in Down's Syndrome Cerebrospinal Fluid
Portelius, E., Soininen, H. S., Andréasson, U., Zetterberg, H., Persson, R., Karlsson, G., Blennow, K., Herukka, S., & Mattsson, N. (2014) · Neurodegenerative Diseases · doi:10.1159/000358800 · Cited by 51
Associations of thyroid hormone serum levels with in-vivo Alzheimer’s disease pathologies
Choi, H. J., Byun, M. S., Yi, D., Sohn, B. K., Lee, J. H., Lee, D. Y., Kim, Y. K., & Lee, D. Y. (2017) · Alzheimer s Research & Therapy · doi:10.1186/s13195-017-0291-5 · Cited by 51
Modulation of Amyloid‐β Aggregation by Histidine‐Coordinating Cobalt(III) Schiff Base Complexes
Heffern, M. C., Velasco, P. T., Matosziuk, L. M., Coomes, J. L., Karras, C. L., Ratner, M. A., Klein, W. L., Eckermann, A. L., & Meade, T. J. (2014) · ChemBioChem · doi:10.1002/cbic.201402201 · Cited by 50
Quantitative Label-Free Proteomics for Discovery of Biomarkers in Cerebrospinal Fluid: Assessment of Technical and Inter-Individual Variation
Perrin, R. J., Payton, J. E., Malone, J. P., Erdmann-Gilmore, P., Davis, A., Xiong, C., Fagan, A. M., Townsend, R. R., & Holtzman, D. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064314 · Cited by 50
Self-citation
The anti-dementia drug candidate, (−)-clausenamide, improves memory impairment through its multi-target effect
Chu, S., Liu, S., Duan, W., Cheng, Y., Jiang, X., Zhu, C., Tang, K. L., Wang, R., Xu, L., Wang, X., et al. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.01.002 · Cited by 50
Cu II Binding to Various Forms of Amyloid‐β Peptides: Are They Friends or Foes?
Borghesani, V., Aliès, B., & Hureau, C. (2017) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.201700776 · Cited by 50
Partial volume correction for PET quantification and its impact on brain network in Alzheimer’s disease
Yang, J., Hu, C., Guo, N., Dutta, J., Vaina, L. M., Johnson, K. A., Sepulcre, J., Fakhri, G. E., & Li, Q. (2017) · Scientific Reports · doi:10.1038/s41598-017-13339-7 · Cited by 50
The E3 ubiquitin ligase Idol controls brain LDL receptor expression, ApoE clearance, and Aβ amyloidosis
Choi, J., Gao, J., Kim, J., Hong, C., Kim, J., & Tontonoz, P. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aad1904 · Cited by 49
Sex-Specific Cross Tissue Meta-Analysis Identifies Immune Dysregulation in Women With Alzheimer’s Disease
Paranjpe, M. D., Belonwu, S., Wang, J. K., Oskotsky, T., Gupta, A., Taubes, A., Zalocusky, K. A., Paranjpe, I., Glicksberg, B. S., Huang, Y., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.735611 · Cited by 49
Multifunctional liposomes delay phenotype progression and prevent memory impairment in a presymptomatic stage mouse model of Alzheimer disease
Mancini, S., Balducci, C., Micotti, E., Tolomeo, D., Forloni, G., Masserini, M., & Re, F. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.05.013 · Cited by 49
Intercommunication between metal ions and amyloidogenic peptides or proteins in protein misfolding disorders
Suh, J., Kim, M., Yoo, J., Han, J., Paulina, C., & Lim, M. H. (2022) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2022.214978 · Cited by 49
Natural β-Dihydroagarofuran-Type Sesquiterpenoids as Cognition-Enhancing and Neuroprotective Agents from Medicinal Plants of the Genus Celastrus
Ning, R., Lei, Y., Liu, S., Wang, H., Zhang, R., Wang, W., Zhu, Y., Zhang, H., & Zhao, W. (2015) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b00234 · Cited by 49
Animal Venom Peptides as a Treasure Trove for New Therapeutics Against Neurodegenerative Disorders
Yang, X., Wang, Y., Wu, C., & Ling, E. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666181031122438 · Cited by 49
Task-evoked fMRI changes in attention networks are associated with preclinical Alzheimer’s disease biomarkers
Gordon, B. A., Zacks, J. M., Blazey, T., Benzinger, T. L. S., Morris, J. C., Fagan, A. M., Holtzman, D. M., & Balota, D. A. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.01.019 · Cited by 49
Self-citation
Focal-type, but not Diffuse-type, Amyloid Beta Plaques are Correlated with Alzheimer’s Neuropathology, Cognitive Dysfunction, and Neuroinflammation in the Human Hippocampus
Liu, F., Sun, J., Wang, X., Jin, S., Sun, F., Wang, T., Yuan, B., Qiu, W., & Ma, C. (2022) · Neuroscience Bulletin · doi:10.1007/s12264-022-00927-5 · Cited by 48
How Zn can impede Cu detoxification by chelating agents in Alzheimer's disease: a proof-of-concept study
Conte‐Daban, A., Day, A. H., Faller, P., & Hureau, C. (2016) · Dalton Transactions · doi:10.1039/c6dt02308h · Cited by 48
RNA induces unique tau strains and stabilizes Alzheimer’s disease seeds
Zwierzchowski-Zarate, A. N., Mendoza‐Oliva, A., Kashmer, O. M., Collazo-Lopez, J. E., White, C. L., & Diamond, M. I. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102132 · Cited by 48
Navigating Early Alzheimer's Diagnosis: A Comprehensive Review of Diagnostic Innovations
Juganavar, A., Joshi, A., & Shegekar, T. (2023) · Cureus · doi:10.7759/cureus.44937 · Cited by 47
Progress in the Treatment of Central Nervous System Diseases Based on Nanosized Traditional Chinese Medicine
Li, J., Long, Q., Ding, H., Wang, Y., Luo, D., Li, Z., & Zhang, W. (2024) · Advanced Science · doi:10.1002/advs.202308677 · Cited by 47
Utilization of precision medicine digital twins for drug discovery in Alzheimer's disease
Ren, Y., Pieper, A. A., & Cheng, F. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00553 · Cited by 48
Reducing Aβ load and tau phosphorylation: Emerging perspective for treating Alzheimer's disease
Kalra, J., & Khan, A. G. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.07.043 · Cited by 47
Amyloid-β pathology induced in humans
Jucker, M., & Walker, L. C. (2015) · Nature · doi:10.1038/525193a · Cited by 47
Grey-matter volume as a potential feature for the classification of Alzheimer’s disease and mild cognitive impairment: an exploratory study
Guo, Y., Zhang, Z., Zhou, B., Wang, P., Yao, H., Yuan, M., An, N., Dai, H., Wang, L., Zhang, X., et al. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1432-x · Cited by 47
Cooperative Roles of Hydrophilic Loop 1 and the C-Terminus of Presenilin 1 in the Substrate-Gating Mechanism of γ-Secretase
Takagi‐Niidome, S., Sasaki, T., Osawa, S., Sato, T., Morishima, K., Cai, T., Iwatsubo, T., & Tomita, T. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.3164-14.2015 · Cited by 47
Evidence for Compromised Insulin Signaling and Neuronal Vulnerability in Experimental Model of Sporadic Alzheimer’s Disease
Gupta, S. N., Yadav, K., Mantri, S. S., Singhal, N. K., Ganesh, S., & Sandhir, R. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0985-0 · Cited by 48
Naringin Dihydrochalcone Ameliorates Cognitive Deficits and Neuropathology in APP/PS1 Transgenic Mice
Yang, W., Zhou, K., Zhou, Y., An, Y., Hu, T., Lu, J. N., Huang, S., & Pei, G. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00169 · Cited by 47
Synthesis and bio-evaluation of new multifunctional methylindolinone-1,2,3-triazole hybrids as anti-Alzheimer's agents
Saeedi, M., Maleki, A., Iraji, A., Hariri, R., Akbarzadeh, T., Edraki, N., Firuzi, O., & Mirfazli, S. S. (2020) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2020.129828 · Cited by 47
Comparative pathobiology of β-amyloid and the unique susceptibility of humans to Alzheimer's disease
Rosen, R. F., Tomidokoro, Y., Farberg, A. S., Dooyema, J., Ciliax, B., Preuss, T. M., Neubert, T. A., Ghiso, J. A., LeVine, H., & Walker, L. C. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.04.019 · Cited by 46
Bacterial sepsis increases hippocampal fibrillar amyloid plaque load and neuroinflammation in a mouse model of Alzheimer’s disease
Basak, J. M., Ferreiro, A., Cohen, L. S., Sheehan, P. W., Nadarajah, C. J., Kanan, M. F., Sukhum, K. V., Dantas, G., & Musiek, E. S. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105292 · Cited by 46
siRNA Mediated GSK3β Knockdown Targets Insulin Signaling Pathway and Rescues Alzheimer’s Disease Pathology: Evidence from In Vitro and In Vivo Studies
Gupta, S. N., Singh, V., Ganesh, S., Singhal, N. K., & Sandhir, R. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c15305 · Cited by 46
Discovery and engineering of an anti-TREM2 antibody to promote amyloid plaque clearance by microglia in 5XFAD mice
Zhao, P., Xu, Y., Fan, X., Li, L., Li, X., Arase, H., Tong, Q., Zhang, N., & An, Z. (2022) · mAbs · doi:10.1080/19420862.2022.2107971 · Cited by 46
Faradarmani Consciousness Field Suppresses Alzheimer’s Disease Development in both in vitro and in vivo Models of the Disease
Taheri, M. A., Torabi, S., Nabavi, N., & Semsarha, F. (2022) · ژورنال علمی کازمواینتل · doi:10.61450/joci.v1i2.18 · Cited by 46
Memory loss in Alzheimer's disease: are the alterations in the UPR network involved in the cognitive impairment?
Duran-Aniotz, C. A., Martínez, G., & Hetz, C. A. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00008 · Cited by 46
Optimization of a Natural Product-Based Class of γ-Secretase Modulators
Hubbs, J. L., Fuller, N. O., Austin, W., Shen, R., Creaser, S. P., McKee, T. D., Loureiro, R. M. B., Tate, B. A., Xia, W., Ives, J. L., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300976b · Cited by 46
High fat diet treatment impairs hippocampal long-term potentiation without alterations of the core neuropathological features of Alzheimer disease
Salas, I. H., Weerasekera, A., Ahmed, T., Callaerts‐Vegh, Z., Himmelreich, U., D’Hooge, R., Balschun, D., Saido, T. C., Strooper, B. D., & Dotti, C. G. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.02.001 · Cited by 46
Circulating antioxidants and Alzheimer disease prevention: a Mendelian randomization study
Williams, D. M., Hägg, S., & Pedersen, N. L. (2018) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy225 · Cited by 46
Molecular Insights into Therapeutic Potentials of Hybrid Compounds Targeting Alzheimer’s Disease
Jana, A., Bhattacharjee, A., Das, S. S., Srivastava, A., Choudhury, A., Bhattacharjee, R., De, S., Perveen, A., Iqbal, D., Gupta, P. K., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02779-6 · Cited by 46
Translational control by eIF2α in neurons: Beyond the stress response
Bellato, H. M., & Hajj, G. N. M. (2016) · Cytoskeleton · doi:10.1002/cm.21294 · Cited by 46
Alzheimer’s disease and sleep disorders: A bidirectional relationship
Chen, J., Peng, G., & Sun, B. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.08.008 · Cited by 45
Disease-Modifying Effects of M1 Muscarinic Acetylcholine Receptor Activation in an Alzheimer’s Disease Mouse Model
Lebois, E. P., Schroeder, J. P., Esparza, T. J., Bridges, T. M., Lindsley, C. W., Conn, P. J., Brody, D. L., Daniels, J. S., & Levey, A. I. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00278 · Cited by 45
Regulation of spine structural plasticity by Arc/Arg3.1
Newpher, T. M., Harris, S. C., Pringle, J., Hamilton, C., & Soderling, S. H. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.09.022 · Cited by 45
MicroRNA-132 is associated with the cognition improvement following voluntary exercise in SAMP8 mice
Dong, J., Liu, Y., Zhan, Z., & Wang, X. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.04.007 · Cited by 45
Alzheimer’s disease: amyloid-based pathogenesis and potential therapies
Zhou, Y., Sun, Y., Ma, Q., & Liu, Y. (2018) · Cell Stress · doi:10.15698/cst2018.07.143 · Cited by 45
Isoliquiritigenin Confers Neuroprotection and Alleviates Amyloid-β42-Induced Neuroinflammation in Microglia by Regulating the Nrf2/NF-κB Signaling
Fu, Y., & Jia, J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.638772 · Cited by 45
Tetrahydrocurcumin ameliorates Alzheimer's pathological phenotypes by inhibition of microglial cell cycle arrest and apoptosis via Ras/ERK signaling
Xiao, Y. M., Dai, Y., Li, L., Geng, F., Xu, Y., Wang, J., Wang, S., & Zhao, J. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111651 · Cited by 45
Association between Sleep, Alzheimer’s, and Parkinson’s Disease
Matsumoto, S., & Tsunematsu, T. (2021) · Biology · doi:10.3390/biology10111127 · Cited by 45
Optogenetics: implications for Alzheimer’s disease research and therapy
Mirzayi, P., Shobeiri, P., Kalantari, A., Perry, G. L., & Rezaei, N. (2022) · Molecular Brain · doi:10.1186/s13041-022-00905-y · Cited by 45
Thiosemicarbazone modification of 3-acetyl coumarin inhibits Aβ peptide aggregation and protect against Aβ-induced cytotoxicity
Ranade, D. S., Bapat, A. M., Ramteke, S., Joshi, B. N., Roussel, P., Tomas, A., Deschamps, P., & Kulkarni, P. P. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.07.028 · Cited by 45
Drug pipeline in neurodegeneration based on transgenic mice models of Alzheimer's disease
Li, C., Ebrahimi, A., & Schluesener, H. J. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2012.09.002 · Cited by 44
Abundant kif21b is associated with accelerated progression in neurodegenerative diseases
Kreft, K. L., van Meurs, M., Wierenga‐Wolf, A. F., Melief, M., van Strien, M. E., Hol, E. M., Oostra, B. A., Laman, J. D., & Hintzen, R. Q. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0144-4 · Cited by 44
Translational inhibition of APP by Posiphen: Efficacy, pharmacodynamics, and pharmacokinetics in the APP/PS1 mouse
Teich, A. F., Sharma, E., Barnwell, E., Zhang, H., Staniszewski, A., Utsuki, T., Padmaraju, V., Mazell, C., Τζέκου, Α., Sambamurti, K., et al. (2018) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2017.12.001 · Cited by 44
Mechanistic insight into the role of metformin in Alzheimer's disease
Sanati, M., Aminyavari, S., Afshari, A. R., & Sahebkar, A. (2022) · Life Sciences · doi:10.1016/j.lfs.2021.120299 · Cited by 44
Cornuside Is a Potential Agent against Alzheimer’s Disease via Orchestration of Reactive Astrocytes
Shi, J.-Z., Zheng, X.-M., Zhou, Y., Yun, L.-Y., Dong-mei, L., Hao, J.-J., Liu, P., Zhang, W., Xu, J., Yan, Y., et al. (2022) · Nutrients · doi:10.3390/nu14153179 · Cited by 44
The multi-functional drug tropisetron binds APP and normalizes cognition in a murine Alzheimer's model
Spilman, P. R., Descamps, O., Gorostiza, O. F., Peters-Libeu, C. A., Poksay, K. S., Matalis, A., Campagna, J. J., Patent, A., Rao, R. V., John, V., et al. (2014) · Brain Research · doi:10.1016/j.brainres.2013.12.029 · Cited by 44

Authors: Holtzman, D. M., Morris, J. C., & Goate, A. M.
Affiliations: Washington University in St. Louis (US)
ORCID: Holtzman, David M.
Morris, John C.
Goate, Alison M.
Venue: Science Translational Medicine
Publisher: American Association for the Advancement of Science (AAAS)
Published: 2011-04-06
Volume: 3
Issue: 77
Pages: 77sr1-77sr1
ISSN: 1946-6234 (ISSN-L)
1946-6242
DOI: 10.1126/scitranslmed.3002369
PMC: PMC3130546
OpenAlex: W2005483591
Cited by: 1,424
References: 225
Citations by year: 2026: 53 · 2025: 81 · 2024: 99 · 2023: 102 · 2022: 93 · 2021: 93 · 2020: 100 · 2019: 124 · 2018: 116 · 2017: 101 · 2016: 92 · 2015: 95 · 2014: 95 · 2013: 86 · 2012: 69
FWCI: 9.56
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Science Translational Medicine (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute on Aging (R01AG035083, RC1AG035654, P50AG005681, P01AG003991, R37AG013956, U19AG032438, U01AG032438, R01AG016208, P01AG026276)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: Alzheimer's disease, dementia, disease prevalence, pathogenesis, translational research, early detection
MeSH terms: Alzheimer Disease, Humans, Amyloid beta-Peptides, tau Proteins, Disease Progression, Presenilins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Alzheimer’s Disease: The Challenge of the Second Century

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks